Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

Completed1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

completed133%
active_not_recruiting133%
unknown133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingphase_2

Causal Mechanisms in Adolescent Arterial Stiffness

NCT04128969
completed

Clinical Outcome of Laparoscopic or Robotic Metroplasty for Uterine Isthmocele

NCT04414670
unknownnot_applicable

Ankaferd Blood Stopper for Hemostasis After Transradial Coronary Angiography

NCT02982733

Clinical Trials (3)

Showing 3 of 3 trials
NCT04128969Phase 2

Causal Mechanisms in Adolescent Arterial Stiffness

Active Not Recruiting
NCT04414670

Clinical Outcome of Laparoscopic or Robotic Metroplasty for Uterine Isthmocele

Completed
NCT02982733Not Applicable

Ankaferd Blood Stopper for Hemostasis After Transradial Coronary Angiography

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3